Get it on Google Play

Seres Therapeutics to present SER-428 preclinical data at IDWeek

October 15, 2026 7:02 AM EDT Send to a Friend
Seres Therapeutics, Inc. (Nasdaq: MCRB) announced it will present preclinical data for SER-428, an investigational oral liquid live biotherapeutic product ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login